Last update:
Medical research
"All things are poison, and nothing is without poison, the dosage alone makes it so a thing is not a poison." These were the words of Paracelsus, a Swiss physician who recognized back in the 16th century that every medicine ...
20 hours ago
0
0
Medications
A research team led by Kobe University Graduate School of Medicine's Professor OGAWA Wataru (the Division of Diabetes and Endocrinology) and Project Associate Professor NOGAMI Munenobu (the Department of Radiology) has discovered ...
Jun 03, 2020
0
32
For patients with granulomatosis with polyangiitis (GPA) or microscopic polyangiitis (MPA), extended therapy with rituximab is associated with a reduced incidence of antineutrophil cytoplasmic antibody-associated vasculitis ...
Jun 03, 2020
0
0
Low-dose aspirin significantly lowers cardiovascular disease risk but increases the risk of bleeding, according to a review published in the British Journal of Clinical Pharmacology.
Jun 03, 2020
0
3
Concerns are mounting about studies in two influential medical journals on drugs used in people with coronavirus, including one that led multiple countries to stop testing a malaria pill.
Jun 02, 2020
4
161
(HealthDay)—A drug championed by President Donald Trump as a coronavirus panacea appears to be in short supply for people who really need it: lupus patients.
Jun 02, 2020
0
2
The malaria drug hydroxychloroquine, which has been promoted as a potential treatment for COVID-19, is known to have potentially serious effects on heart rhythms. Now, a team of researchers has used an optical mapping system ...
Jun 01, 2020
0
17
The drug Tagrisso could offer hope to patients battling a form of lung cancer that typically hits people with little or no history of smoking, a new trial finds.
Jun 01, 2020
0
55
People taking hydroxychloroquine for coronavirus may be more likely to die, according to new research. But that doesn't mean the drug is killing them.
Jun 01, 2020
0
6
Worldwide more physicians are using remdesivir to treat COVID-19 patients, according to a survey released May 21 by Sermo, a global health care polling company and social platform for physicians.
Jun 01, 2020
0
3
The VA health system has stopped nearly all use of hydroxychloroquine to treat COVID-19 patients, Veterans Affairs Secretary Robert Wilkie said at a House hearing on Thursday.
Jun 01, 2020
0
4
Dozens of scientists have raised concerns over a large-scale study of hydroxychloroquine and chloroquine published in the Lancet that led to the World Health Organization suspending clinical trials of the anti-viral drugs ...
May 29, 2020
12
1662
Doctors are reporting success with newer drugs that control certain types of cancer better, reduce the risk it will come back and make treatment simpler and easier to bear.
May 29, 2020
0
29
A new study by investigators from Brigham and Women's Hospital examines changes in prescription patterns in the United States during the COVID-19 pandemic.
May 29, 2020
0
47
U.S. health regulators are telling five drugmakers to recall their versions of a widely used diabetes medication after laboratory tests found elevated levels of a contaminant linked to cancer.
May 29, 2020
0
283
(HealthDay)—There seems to be no significant difference between a five- and 10-day course of remdesivir for patients with severe COVID-19 not requiring mechanical ventilation, according to a study published online May 27 ...
May 29, 2020
0
5
(HealthDay)—For men with advanced prostate cancer, the oral gonadotropin-releasing hormone (GnRH) antagonist relugolix maintains testosterone suppression compared with the GnRH agonist leuprolide, while enzalutamide is ...
May 29, 2020
0
4
A large international trial involving UCL and University College London Hospitals NHS Foundation Trust (UCLH) has found that pembrolizumab, a form of immunotherapy, more than doubled the 'progression free survival' time of ...
May 29, 2020
0
2
(HealthDay)—Large pharmacy chains, including CVS, Rite Aid, Walgreens, Giant Eagle, and those operated by Walmart, played a role in the U.S. opioid epidemic, alleges a lawsuit filed in federal court in Cleveland by two ...
May 29, 2020
0
1
Patients with advanced non-small cell lung cancer (NSCLC) and the MET exon 14 (METex14) skipping mutation had a 46.5% objective response rate to the targeted therapy drug tepotinib, as shown in a study published today in ...
May 29, 2020
0
2
